March - 20234IN MY OPINION08COVER STORY 12LAST WORD30THE IMPORTANCE OF INDEPENDENT SAFETY INPUT INTO THE MEDICAL DEVICES R&D PROCESSAaron Goodstein, Director of Quality Systems & Compliance, MD&D Medical Safety, Johnson & Johnson [NYSE:JNJ]TELOS PARTNERSTELOS PARTNERSOFFERING ROBUST REGULATORY SUPPORT TO THE EVOLVING BIOTECH INDUSTRYCONTENTSSCOTT DAY,VP AND GENERAL MANAGERADOPTING eQMS­THE NEXT GENERATION OF QUALITYRolando E. Ardon, MB, Director, Quality and Regulatory Compliance,UFP Technologies, Inc. [NASDAQ:UFPT]
< Page 3 | Page 5 >